Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2026-01-31 @ 2:31 AM
Study NCT ID:
NCT01884259
Status:
COMPLETED
Last Update Posted:
2022-05-26
First Post:
2012-05-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN
Sponsor:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05
Start Date Type:
None
Primary Completion Date:
2021-01-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-13
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-18
First Submit QC Date:
None
Study First Post Date:
2013-06-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-20
Last Update Post Date:
2022-05-26
Last Update Post Date Type:
ACTUAL